KemPharm’s new ADHD drug to launch this year

A Celebration-based company’s innovative treatment for attention deficit hyperactivity disorder will hit the shelves this year. 

The U.S. Food and Drug Administration on March 2 approved the application for a treatment developed by pharmaceutical firm KemPharm Inc., called Azstarys. The commercialization of this drug likely will create jobs at the company, which currently has 23 employees, CEO Travis Mickle previously told Orlando Business Journal. Read more here.